High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes.

NPJ Breast Cancer · 2022 · PMC9427744 · PMID 36042244

Europe PMC DOI

hedged sentence

0.0140

closest p · 0.3× alpha

0.0140

boldest claim

The sentences

a significant trendP = 0.014actually significant

At a median follow-up interval of 67.1 months, a significant trend towards reduced distant metastasis-free survival (DMFS) ( P = 0.014) was found by Kaplan–Meier analysis in patients with high GPER expression.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.